Nine for 2023, part one: a reflection on inflection
pharmaphorum
JANUARY 9, 2023
1 Kenya, for example, entered the pandemic with no human vaccines manufacturing facility and established the BioVax institute for local vaccine manufacture with a major plant investment starting in 2023. For pharma, the impact in critical areas such as the performance of newly marketed innovation has already been documented.
97 
Let's personalize your content